Word

BAM

Status

Registered

Status Code

700

Status Date

Tuesday, September 29, 2020

Serial Number

88428843

Registration Number

6161365

Registration Date

Tuesday, September 29, 2020

Mark Type

4000

Filing Date

Tuesday, May 14, 2019

Published for Opposition

Tuesday, April 14, 2020

Trademark Owner History

Syneos Health, LLC - Original Registrant

Classifications

41 Education services, namely, providing non-downloadable webinars, providing live workshops, providing seminars through on-line non-downloadable videos, providing on-line non-downloadable electronic publications in the nature of articles and white papers, and providing non-downloadable podcasts, all the foregoing in the field of pharmaceutical sales; training services in the field of pharmaceutical sales; providing on-line non-downloadable electronic newsletters and bulletins in the pharmaceutical, biotechnology and life sciences fields; educational services, namely, providing courses offered through on-line non-downloadable videos, non-downloadable webinars, live workshops, providing online non-downloadable electronic publications in the nature of articles and white papers, and providing non-downloadable podcasts, all the foregoing in the field of clinical trials

35 Strategic business consulting, information and data collection, namely, compiling and analyzing data and information for business purposes, and business data analytics, namely, analyzing business data to understand and evaluate business performance, all of the aforementioned in the pharmaceutical, biotechnology and life sciences fields; market analysis and research services; personnel recruitment and placement; recruitment advertising services, namely, advertising clinical trials for the purpose of recruiting patients, and placing patients for participation in clinical trials for testing of pharmaceuticals and devices; consulting in sales techniques and sales programs; sales volume tracking for others, all in the pharmaceutical, biotechnology and life sciences fields; business consulting in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting pharmaceutical and biotechnology companies with preparing and filing applications for new drugs with governmental regulatory bodies; promoting the exchange of health information within the pharmaceutical, biotechnology and life sciences communities to promote patient adherence within the field of pharmaceutical, biotechnology and life sciences clinical trials; extended clinical research services for others, namely, computerized data management of clinical trials

44 Providing medical information to physicians, other health care professionals and medical patients; providing health information regarding the medications and health care products of others through e-mail alerts and push notifications, namely, providing information concerning product discontinuations; providing health information concerning new formulations of medications and health care products of others through e-mail alerts and push notifications, namely, providing information in the field of pharmaceutical products development; providing health information concerning bottle changes of medications and health care products of others through e-mail alerts and push notifications, namely, providing information in the field of bottle product design, and seasonal information in the nature of reports on pharmaceutical products development

42 Medical and scientific data analysis research services for others, namely, conducting and analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; pharmaceutical drug development services, namely, developing clinical trial methodologies; consulting services in the area of pharmaceutical product clinical testing; extended clinical research services for others for medical purposes, namely, biostatistical analysis for scientific research purposes, preclinical research in the field of pharmaceuticals, biotechnology, and medical sciences, development evaluation, namely, clinical feasibility assessment of protocols and patient recruitment strategies, repairing flawed clinical trials and dossiers, namely, medical and scientific research in the nature of conducting clinical trials for others, and strategic clinical research portfolio management, namely, consulting services for others in the project management of clinical research; extended clinical research services for others in the field of pharmaceuticals, biotechnology, and life sciences, namely, biostatistical analysis for scientific research purposes; providing life science and scientific research information to physicians and other health care professionals, patients, and medical, pharmaceutical and biotechnology companies; providing regulatory compliant technical writing services in the field of medical research and clinical studies; consulting services in the field of contract clinical research and contract product development

Trademark Events

Oct 4, 2023

Assignment Of Ownership Not Updated Automatically

Mar 15, 2023

Assignment Of Ownership Not Updated Automatically

Sep 29, 2020

Registered-Principal Register

Aug 23, 2020

Extension Of Time To Oppose Process - Terminated

May 14, 2020

Extension Of Time To Oppose Received

Apr 14, 2020

Official Gazette Publication Confirmation E-Mailed

Apr 14, 2020

Published For Opposition

Mar 25, 2020

Notification Of Notice Of Publication E-Mailed

Mar 6, 2020

Approved For Pub - Principal Register

Mar 3, 2020

Examiner's Amendment Entered

Mar 3, 2020

Notification Of Examiners Amendment E-Mailed

Mar 3, 2020

Examiners Amendment E-Mailed

Mar 3, 2020

Examiners Amendment -Written

Feb 8, 2020

Teas/Email Correspondence Entered

Feb 7, 2020

Correspondence Received In Law Office

Feb 7, 2020

Teas Response To Office Action Received

Aug 7, 2019

Notification Of Non-Final Action E-Mailed

Aug 7, 2019

Non-Final Action E-Mailed

Aug 7, 2019

Non-Final Action Written

Jul 31, 2019

Assigned To Examiner

May 30, 2019

New Application Office Supplied Data Entered

May 17, 2019

New Application Entered